Research & Development
A Pipeline Built for Precision.
Our programs target the genomic drivers of cancer with therapies designed to adapt — delivering precision at every stage of the disease.
Our Approach
Monarch Therapeutics applies a genomics-first methodology to drug discovery and development. By profiling the unique mutational landscape of each tumor type, we identify high-value targets and design adaptive therapeutic strategies that respond to tumor evolution in real time.
Programs
Development Pipeline
Solid Tumors — Genomic Subsets
Oncogenic Driver Mutations
Small Molecule / Targeted Therapy
Hematologic Malignancies
Adaptive Resistance Pathways
Biologic / Combination
Rare Genomic Cancers
Tumor Suppressor Restoration
Gene-Targeted Therapy
Immunotherapy Resistance
Immune Evasion Mechanisms
Immuno-Oncology
How We Work
Scientific Pillars
Genomic Profiling
Deep sequencing and multi-omic analysis to identify actionable targets across tumor types.
Adaptive Design
Therapeutic platforms engineered to respond to tumor evolution and acquired resistance.
Translational Science
Seamless integration of laboratory discovery with clinical development strategy.
Partner With Us
We actively seek collaborations with academic centers, biotech partners, and clinical networks to accelerate our pipeline.
Contact Us